Cornerstone Advisory, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Cornerstone Advisory, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 20, 2022	SELL	$1.83 - $3.02 $45 - $75	-25 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$2.88 - $4.3 $72 - $107	25 New	25 $0

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Advisory, LLC with notifications on news.